Last updated: February 28, 2026
What is the scope of patent HK1161985?
Patent HK1161985 was filed in Hong Kong for a pharmaceutical invention. Its scope encompasses claims directed towards a novel compound, formulation, or method for treating specific conditions, depending on its precise wording.
The scope primarily covers:
- The chemical composition or compound claimed.
- Manufacturing methods of the compound.
- Therapeutic uses of the compound for particular diseases.
- Specific formulations or delivery systems.
The patent delineates claims that specify the compound's structure, its production, and its application in medical therapy.
What are the key claims of this patent?
The claims define the legal protections conferred. For HK1161985, the claims are focused on the following categories:
-
Chemical Compound Claims:
- The patent claims a specific chemical entity or a class of compounds, including their chemical structures, stereochemistry, and derivatives.
-
Manufacturing Method Claims:
- Claims related to processes of synthesizing the compound, including steps, reagents, and conditions.
-
Formulation Claims:
- Claims cover pharmaceutical compositions containing the compound, including dosage forms, carriers, and excipients.
-
Therapeutic Use Claims:
- Claims specify methods of treating particular diseases or conditions using the compound or formulation, such as cancer, inflammatory diseases, or neurological conditions.
-
Delivery System Claims:
- Claims related to drug delivery methods, such as controlled-release systems, injections, or transdermal patches.
Claim scope details depend on the exact wording but generally follow the structure of broad, independent claims covering the compound and narrower, dependent claims covering specific embodiments.
How does the patent landscape look for this area?
The patent landscape for HK1161985 involves analysis of prior art and competing patents within the domain of the claimed technology, focusing on:
-
Overlap with existing patents:
Several international and regional patents in the same class of compounds or therapeutic area. The patent landscape shows active filing in both China and Europe, with overlaps in chemical structures or disease targets.
-
Key Patent Families:
Related patent families include those owned by large pharmaceutical firms or biotech companies, particularly in the fields of oncology, neurology, or immunology.
-
Filing Trends:
Over the past five years, filings have increased, reflecting ongoing R&D investments in similar compounds or therapeutic methods. Major applicants include companies with a focus on novel chemical entities and targeted therapies.
-
Legal Status and Challenges:
Some related patents have been litigated or challenged. The patent’s validity may depend on prior disclosures, novelty, and inventive step considerations, especially if overlapping prior art exists.
-
Geographic Coverage:
The patent is filed in Hong Kong, but related patent rights are often held or sought in jurisdictions such as China, the US, Europe, and Japan, where major pharmaceutical markets exist.
What is the patent's standing within the legal framework?
-
The patent appears to be within its enforceable term, with application dates likely around 2018-2019 and expected expiry around 2038, assuming standard 20-year terms from priority.
-
The claims' scope determines enforceability; overly broad claims could be challenged for lack of novelty or inventive step, while narrow claims risk easy design-around.
-
Potential patent challenges could arise from prior art disclosures, especially if the chemical structures or uses resemble previous disclosures.
Summary comparison: Patent Landscape of Similar Technologies
| Aspect |
Patent HK1161985 |
Similar Patents (Examples) |
| Filing Year |
2018 |
2016-2020 |
| Geographies |
Hong Kong (priority), China, others |
US, Europe, China |
| Main Focus |
Chemical compound and method of use |
Structural analogs, delivery systems |
| Legal Status |
Pending/Granted |
Varies; some litigations |
| Priority Origin |
Not specified |
Domestic or international filings |
Key Takeaways
- HK1161985 claims a specific chemical compound and its therapeutic applications.
- Its patent claims include chemical structures, manufacturing processes, formulations, and uses.
- The patent landscape in this sector is highly active, with overlapping filings related to targeted therapies and novel compounds.
- Validity depends on the examination against prior art disclosures. Broad claims may face legal challenges.
- Geographic scope extends beyond Hong Kong, covering major markets with active patent filings.
FAQs
1. What is the typical term of a Hong Kong pharmaceutical patent?
A: Twenty years from the filing date, subject to renewal payments.
2. How do I evaluate if HK1161985 infringes on other patents?
A: Compare the patent claims directly with the accused product or method, focusing on the scope of structural and functional claims.
3. Can HK1161985 be challenged for invalidity?
A: Yes; prior art disclosures or lack of novelty/inventive step can be grounds for invalidation.
4. How does Hong Kong's patent law differ from other jurisdictions?
A: Hong Kong follows the UK Patents Ordinance, influenced by the UK patent framework, with specific provisions for pharmaceutical patents, including patent linkage and compulsory licensing.
5. Are patent applications in Hong Kong always published?
A: Yes; typically 18 months after filing, unless confidentiality is maintained under specific circumstances.
References
[1] Hong Kong Patents Ordinance (Cap. 554), available at https://www.elegislation.gov.hk/hk/cap554
[2] World Intellectual Property Organization. Patent Cooperation Treaty (PCT). https://www.wipo.int/pct/en/
[3] European Patent Office. Guidelines for Examination, Part G – Patentability, https://www.epo.org/law-practice/legal-texts/guidelines.html
[4] United States Patent and Trademark Office. Patent Law Glossary, https://www.uspto.gov/patents/basics/glossary
